Showing results (31-40 of 64) with videos related to
Sort By:
Pageof 7
Journal of Virology|July 1, 1993
Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader regionJ H Richardson, L A Child, A M LeverJournal of Virology|June 17, 1998
Functional analysis of the core human immunodeficiency virus type 1 packaging signal in a permissive cell lineG P Harrison, G Miele, E Hunter, et al.The Journal of Infection|July 1, 1994
Fatal melioidosis in a tourist returning from ThailandD Wilks, S K Jacobson, A M Lever, et al.The Journal of Infection|February 29, 2012
Superiority of 18F-FDG PET compared to 111In-labelled leucocyte scintigraphy in the evaluation of fever of unknown originN Seshadri, L I Sonoda, A M Lever, et al.Hepatology (Baltimore, Md.)|January 1, 1989
Defective response to interferons in cells transfected with the hepatitis B virus genomeM Onji, A M Lever, I Saito, et al.Gut|December 1, 1986
Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infectionT Ikeda, M Pignatelli, A M Lever, et al.Nucleic Acids Research|August 1, 1996
Sequences involved in the dimerisation of human T cell leukaemia virus type-1 RNAJ S Greatorex, V Laisse, M C Dockhelar, et al.The Journal of General Virology|January 21, 2000
Virus inactivation in a proportion of human T-cell leukaemia virus type I-infected T-cell clones arises through naturally occurring mutationsN J Rose, J H Richardson, U Desselberger, et al.The Journal of General Virology|January 21, 2000
A 37 base sequence in the leader region of human T-cell leukaemia virus type I is a high affinity dimerization site but is not essential for virus replicationI Le Blanc, J Greatorex, M C Dokhélar, et al.Lancet (London, England)|March 7, 1987
Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapyB J Thomson, M Doran, A M Lever, et al.Pageof 7